[HTML][HTML] Perspectives of Women with Breast Cancer and Healthcare Providers Participating in an Adherence-Enhancing Program for Adjuvant Endocrine Therapy: A …
V Turcotte, L Guillaumie, M Lemay, A Dionne… - Current …, 2025 - mdpi.com
Background: Adjuvant endocrine therapy (AET) is prescribed for 5–10 years to women with
hormone-sensitive breast cancer to prevent recurrence. However, a significant proportion of …
hormone-sensitive breast cancer to prevent recurrence. However, a significant proportion of …